The ongoing ICE enforcement actions and resulting protests in Minnesota may be contributing to serious public health problems.

The settlement is expected to drive down patients' out-of-pocket costs for drugs such as insulin by up to $7 billion over 10 years.

This investment comes after news of the Trump administration abruptly canceling hundreds of federal grants nationwide that support substance abuse treatment.

Although it was expected to go live in late January, HHS Secretary Robert F. Kennedy Jr. announced at a cabinet meeting last week that it instead "is going to be happening sometime, probably in the next 10 days."

The former employees argue that the company was involved in self-dealing and prohibited transactions under ERISA because it designed its own funds, picked the managers, decided how assets were allocated and then collected related fees.

When cost is removed as an option, the public rank prior authorization as the biggest problem, the latest KFF Heath Tracking Poll found.

"Without real-time supply-chain visibility, teams are forced to make critical decisions with incomplete information." said Jeff Wagner vice president of pharmacy, respiratory care and ECMO services for Texas Children's Hospital.

The complaint, filed by the law firm Sanford Heisler Sharp McKnight, alleges that Bloomberg failed to remove two funds from its plan after they performed poorly for more than a decade.